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Abstract
BACKGROUND: Recent studies have found that OSA without the use of CPAP is an
independent risk factor for cardiovascular disease and hypertension, which can lead to
myocardial infarction (MI) and cerebral vascular accident (CVA) or stroke. This increases
patient morbidity and mortality rates as well as medical costs. In those suffering from a
myocardial infarction (MI) or cardiovascular accident (CVA), an important intervention is proper
screening for the presence of OSA while in the acute care setting. The STOP BANG screening
instrument is a simple yet effective tool in assessing for sleep apnea symptoms with a respective
sensitivity of 93% for detecting moderate OSA and 100% in detecting severe OSA.
OBJECTIVE: To educate participating nursing staff on using the STOP BANG screening
instrument, and implementing it within the MI and CVA populations. After completion of the
implementation period, screening adherence was assessed as well as patient demographics.
METHODS: A literature review was conducted and the STOP BANG screening instrument was
selected to assess for OSA. Participating nurses were educated on the use of the STOP BANG
screening instrument who then implemented the tool on the MI and CVA populations. A pilot
study was conducted that utilized a descriptive and qualitative study and involved a retrospective
chart review that was one time only, and included a two-part study. The setting was within the
ICU and 5 East Cardiac Units of Norton Brownsboro Hospital (NBH) from September 28, 2017
through December 17, 2017. RESULTS: The participation rate in the ICU was 78% and 100%
in the 5 East Cardiac unit. Within the ICU a 60% screening adherence rate was achieved for
CVA patients with a 40% non-adherence rate. For MI patients a 38% adherence rate was
achieved for the ICU and 5 East units combined, and a 62% non-adherence rate. Among patient
demographics, results were as follows: positive screens requiring supplemental oxygen was
(P=.214), positive screens vs negative screens and the use of BiPAP were (P=.074) and
1

(P=1.000), notes made in records for positive screens were 9 out of 18 or 50% adherence.
CONCLUSIONS: Nurse provider participation was high within the ICU and 5 East Cardiac
units. Screening adherence was higher among the CVA patient population compared to the MI
population. There was no significance or correlations between the use of supplemental oxygen or
the use of BiPAP, and positive STOP BANG screens. There was statistical significance between
male patients with higher BMI's and positive STOP BANG screens. These results indicate that
more research is required with larger sample sizes and multiple facilities to acquire more reliable
results for generalizability.
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Background
Cardiovascular disease and hypertension are two factors in the development of myocardial
infarction (MI) and cerebral vascular accident (CVA) or stroke. Recent studies indicate that
obstructive sleep apnea (OSA) without the use of continuous positive airway pressure (CPAP) is
an independent risk factor for cardiovascular disease and hypertension (Martinez-Garcia et al.
2013; Barbe et al. 2012; Chen et al. 2015). Chen et al. (2015) concluded that in elderly patients,
the risk of death in those without CPAP therapy was higher than those with it. Obstructive sleep
apnea has been identified through large epidemiological studies to be an independent risk factor
for stroke (Barone & Krieger, 2013). A study with more than 6000 patients demonstrated that
those with OSA has a 3 and 4-fold increased odds ratio for ischemic heart disease and
cerebrovascular disease compared to the control population (Barone & Krieger, 2013).
Cardiovascular disease and stroke are major causes of morbidity and mortality in the
United States. Cardiovascular disease is the leading cause of death for both men and women.
Around 610,000 or 1 in 4 people die from it each year (Centers for Disease Control and
Prevention [CDC], 2015). The U.S. spends $108.9 billion dollars annually to cover lost
production, medications and health care services from cardiovascular disease (CDC, 2015).
Stroke is a major cause of disability in the U.S. and the fifth leading cause of death (CDC, 2016).
Each year 1 person dies about every four minutes in the U.S. from a stroke which is about
130,000 people or 1 in 20 deaths (CDC, 2016). About 800,000 people suffer from a stroke each
year and the U.S. spends $34 billion in health care costs including medications and missed days
of work (CDC, 2016).
This background information reveals that OSA is a risk factor for cardiovascular disease
that can impact healthcare and costs. There are no OSA screening tools within the Norton
3

Healthcare system other than the peri-operative area of Norton Brownsboro Hospital that only
screens for OSA in surgical patients. To implement a protocol such as the STOP BANG
screening instrument, evidence must support the education as a means for implementing
evidence-based practice. The Iowa Evidence-based Practice Model is an example of how to
bring evidence into practice and uses a 7-step process to introduce, develop and evaluate
evidence-based practice (British Journal of Medicine, 2011). The model promotes the quality of
patient care, helps control healthcare costs, and can be used to implement practice change at the
unit or organization level (Brown, 2014). This model could be useful in implementing a practice
change such as the STOP BANG screening instrument within the Norton Healthcare
organization.
Screening Instruments
A literature review was completed to choose an appropriate OSA screening instrument
for the MI and CVA populations. The databases Medline, PubMed, Ebscohost, and CINAHL
were used to search for current evidence using the terms, obstructive sleep apnea screening,
obstructive sleep apnea questionnaire, testing, MI, CVA, and cardiovascular health. The results
were limited to English, age 18+, and published within the last 10 years.
A total of 6 studies were chosen that met the criteria. The literature review provided
evidence that the most reliable and accurate OSA screening tools were the STOP BANG
questionnaire, Berlin questionnaire, and Epworth Sleepiness Scale. A tool needed to be selected
which was not only reliable and accurate but easy to use in a timely manner by nursing staff.
The Amra et al., (2018), recommended a sleep study with Polysomnography (PSG) as the gold
standard diagnostic but compared the 3 questionnaires. Their results indicated the sensitivities of
the Berlin, STOP-BANG, and ESS were 86.42%, 81.46%, and 59%, respectively. Specificities
4

of Berlin, STOP-BANG, and ESS were 52.94%, 82.35%, and 76.47%, respectively. They
concluded the Berlin and STOP-BANG were more sensitive and accurate than the Epworth
Sleepiness Scale in screening for OSA. A systematic review and meta-analysis of 9,206 patients
by (Nagappa et al., 2015), examined the validation of the STOP BANG questionnaire as a
screening tool for OSA. The study revealed that the STOP-BANG questionnaire had a 94% and
96% sensitivity in detecting moderate to severe and severe sleep apnea. It was also stated the
STOP-BANG is a practical, short, straight forward test that takes approximately 1-2 minutes, and
has a 90-100% response rate. Their conclusion was that the STOP-BANG has a high
performance and the higher the score, the higher the probability of moderate to severe sleep
apnea. A study by Chung et al. (2016), associated with the American College of Chest
Physicians, concluded that the STOP-BANG is a concise, effective, and reliable OSA screening
tool with a sensitivity to detect moderate to severe OSA and severe OSA of 93% and 100%. In
comparing the 3 questionnaires, it concluded that the STOP BANG was a more accurate tool for
detecting mild, moderate and severe sleep apnea (Chung et al. 2016). For the Berlin, STOPBANG and Epworth, the pooled sensitivity levels for moderate sleep apnea were 77%, 90%,
40%, and specificity levels were 44%, 36% and 62%. For severe sleep apnea the sensitivity
levels were 84%, 93% and 58%, and specificity levels were 38%, 35% and 60%. No benchmark
data from similar “best practice” institutions or programs could be found specifically for OSA
screening pertaining to MI and CVA within the acute care setting. However, a QI project
conducted by the American Society of Peri-Anesthesia Nurses in 2011, revealed a safer patient
perioperative environment was created by incorporating the STOPBANG screening tool. The
pilot project used the Iowa Model of evidence based practice and reviewed patient data pre- and
post implementation of the OSA screening tool (Lakdawala, 2011). According to Chung et al.
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(2012), the STOP-BANG is a simple yet effective tool in assessing for sleep apnea symptoms
with a respective sensitivity of 93% for detecting moderate OSA and 100% in detecting severe
OSA.
After reviewing the literature, the STOP-BANG tool is a valid and reliable instrument in
screening for sleep apnea that is quick and simple to use. STOPBANG is an acronym that stands
for Sleepiness, Tiredness, Observed apnea, high blood Pressure (STOP), BMI, Age, Neck
circumference, Gender (BANG). Scores range from 0-8 where higher scores equal higher risks.
Scores from 0-2 are classified as low risk for moderate to severe OSA, where scores of 5-8 are
classified as high risk according to (Chung et al. 2013). Scores between 3-4 require further
criteria for classification. An example would be a patient with a score > 2 but has a BMI of 35,
would be classified as high risk for having moderate to severe OSA (Chung et al. 2013). A study
by Chung et al. (2012), evaluated the association between STOP BANG scores and the
probability of OSA. The study concluded that a score of 5-8 identified patients as having a high
probability of having moderate to severe OSA. It is important to note that the STOP BANG
screening tool is only for assessing for symptoms of OSA and is not diagnostic indicator.
Purpose
The specific aims of this study were to implement the STOP BANG protocol within the
Norton Brownsboro ICU and 5 East Cardiac units, evaluate adherence to the protocol by the
health care providers to the protocol, and determine if there is an association between positive
STOP BANG screens and the use of supplemental oxygen or BiPAP. Implementation of the
project involved education of at least 75% of the ICU and 5 East nurses on how to use the STOP
BANG protocol, measurement of protocol adherence, and retrospective data collection from the
electronic medical record from the MI (DRG 280-282) and CVA (061-068) patient population to
6

measure the association between positive STOP BANG screens and the use of supplemental
oxygen or BiPAP. The six following research questions guided this study.
1. Was 75% of the nurses within the ICU and 5 East Cardiac units educated on how to
use the STOP BANG screening instrument?
2. Was screening with the STOP BANG instrument adhered to within the units for the
specified populations?
3. Why was there screening non-adherence during the implementation phase?
4: What proportion of patients who screened positive on the STOP BANG tool required
oxygen supplementation or increased oxygen requirements at night?
5. Between those whose screened negative vs positive on the STOP BANG tool, who
required use of BIPAP during nighttime hours during the implementation phase?
6. Was a note made in EPIC that the patient was given an education handout explaining a
positive screen on the STOP BANG screening tool?
Methods
This evidence-based quality improvement project utilized a descriptive design to evaluate
implementation and adherence to the STOP BANG screening protocol. Additionally, a
retrospective chart review was done to determine adherence to the protocol and to collect data to
identify association between STOP BANG screening assessments (positive or negative) and use
of BiPAP and oxygen requirements. The target facility was the Norton Brownsboro ICU and 5
East cardiac unit. This study had two parts, part one of the study evaluated effectiveness of the
implementation of the protocol by determining the percentage of the registered nurses who
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received training on how to use the STOP BANG protocol. The primary investigator provided
training on using the STOP BANG protocol during shift starts. The education was started on
9/28/2017 and lasted for one week to cover all shifts and consisted of how to implement the
STOP BANG protocol (see Appendix A). The registered nurses were educated to screen any
patient that was admitted with an MI or CVA with the STOP BANG protocol. This involved
screening the patient with the 8 questions on the STOP BANG screening instrument (see
Appendix A) and adding the "yes" column to obtain a score. A positive score was between 5-8
and indicated the patient was at higher risk for having moderate to severe OSA. In the event a
patient screened positive, the registered nurse was to place a note in the patient's chart stating
they received a positive screen and was given an education handout (see Appendix B) explaining
what this score meant and they should follow up with their primary care provider post discharge.
The education handout was not given to patients with negative screens, however, the RN was
asked to explain to the patient the purpose of the screen. If a patient was not screened, the
registered nurse was to make a note in the chart explaining why the screening was not
completed. Once screening was completed, the registered nurse then scanned the hard copy of
the STOP BANG screening instrument into the EMR. A roster of the ICU and 5 East nurses was
given to the primary investigator from the unit managers. This was compared to those who
attended the training sessions and checked for duplicates. There was a desired goal of at least
75% of the nurses to attend training. The second part of the study included a retrospective
review of the EMR on all patients admitted to the ICU with an MI (DRG 280-282) or CVA
(DRG 061-068), and 5 East with an MI (DRG 280-282) during the protocol implementation
period. The purpose of the chart review is to have measurable data for the objectives and assess
adherence to the STOP BANG protocol, the reason the protocol was not adhered to, what
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proportion of those patients who screened positive required oxygen at night or higher oxygen
requirements, and compare BiPAP requirements in patients who screened positive with those
who screened negative on the STOP BANG protocol. The retrospective chart review also
assessed if the patient who screened positive on the protocol received education via a handout on
what a positive STOP BANG screen means. The demographic variables of age, race and gender
were measured in all patients admitted to the ICU with an MI (DRG 280-282) or CVA (061-068)
and 5 East with an MI (DRG 280-282): Other patient characteristics, that were not part of the
study objectives, were evaluated to see if patients had incidents such as: BMI, pacemaker
present, admission diagnosis of MI (DRG 280-282) or CVA (061-068), intubation, tachycardia,
bradycardia, and the presence of Atrial fibrillation or Aflutter. These variables were recorded
into a data collection tool on an Excel spreadsheet (see Appendix C).
Setting
The Norton Brownsboro Hospital ICU and 5 East Cardiac units located in Louisville,
KY. is the setting of this study. The study focused on OSA, which is a risk factor for
cardiovascular disease, and this setting was chosen due to Norton Brownsboro Hospital being a
comprehensive stroke center that has achieved advanced certification from the Joint Commission
and American Heart Association. There is a high rate of admittance of CVA patients to the ICU
which focuses on neurosurgery but also admits STEMI patients. The ICU has a total of 36 beds
with 16 beds located on the third floor and 20 beds located on the fifth floor. The 5 East Cardiac
unit has 21 beds and admits NSTEMI patients. The study time frame was from September 28,
2017 thru December 17, 2017.
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Sample
The STOP BANG protocol was implemented as a pilot study where the primary investigator
educated on the need, protocol and instrument use as part of an OSA screening protocol in a
population of patients. The study was to evaluate the implementation of the STOP BANG
protocol and education was provided to a mass of nurses. The primary investigator then
measured the effectiveness of the implementation process on adherence to the STOP BANG
protocol. Data was also analyzed to determine associations/correlations between STOP BANG
screening results and use of oxygen and BiPAP in patients who screened positive compared with
those who screened negative to better understand effectiveness of implementing an OSA
screening protocol in a high-risk population.
The sample for this study consisted of two populations. The primary population was the
Norton Brownsboro ICU and 5 East staff nurses who participated in the education sessions
during implementation of the STOP BANG screening instrument. Nurses were asked to
participate in the study by the primary investigator. Participation was strictly voluntary and each
nurse that participated signed consents explaining the study. Approximately 80 nurses from the
ICU were invited to participate, and 5 nurses from the 5 East cardiac unit. All staff nurses who
declined to participate were excluded from the study which resulted in a primary population of
63 nurses from the ICU and 5 nurses from 5 East with a total number of 68. Agency nurses were
excluded from the study.
The secondary population of interest were those who suffered an MI or CVA during the
period from Sept 28 through Dec 17, 2017, and met the inclusion criteria. The inclusion criteria
included patients admitted to the ICU with a diagnosis of myocardial infarction including a
STEMI or NSTEMI, or cerebral vascular accident including Ischemic or Hemorrhagic strokes.
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On 5 East those admitted with a NSTEMI were included (please refer to table 1 for a
comprehensive list of DRG diagnosis codes used for inclusion criteria during admission). Other
inclusion criteria were those 18 years of age or older, and patients that were competent or able to
answer the questions on the STOP BANG screening instrument. If the patient was intubated,
awake and could follow commands, family or friends could answer the questions on the STOP
BANG screening instrument for the patient.

Non-English-speaking patients were included in

the criteria as translator phones were available on the units. Exclusion criteria were those
younger than 18 years of age, and non-verbal or non-mentation patients with a decreased
Glasgow Coma Scale who was not able to follow commands or answer questions.
Data Collection
Approval from the Norton Healthcare Office of Research Administration (NHORA) and
University of Kentucky Institutional Review Board (IRB) was obtained before any data was
collected. The names of staff nurses who participated in the study, and signed consents given to
them by the primary investigator, were obtained through rosters provided by the unit managers to
obtain the percentage of nurses that participated in the study. The study only involves the
implementation of the STOP BANG protocol in a population of practicing nurses using an
education approach and evaluation of adherence.
To collect patient data, an official request for secured data was submitted to the Norton
Healthcare Office of Research Administration to identify and obtain reviewable patient records
using the DRG codes listed in Table 1. Data from the EPIC EMR was gathered at the Office of
Nursing Research (room 5202) in a private room with a computer that was used to access patient
charts. The medical record number (MRN) was used to access patient charts. A total of 52
records were returned that met the DRG criteria for MI's and 129 records that met the DRG
11

criteria for CVA's for a total of 181 records. The primary investigator (PI) entered the 181
records to assess if screening was implemented. Of the 52 records for MI's, 18 patients had
screening adherence. From the 34 remaining records, 28 did not have screening adherence, and
6 records did not meet the inclusion criteria. Of the 129 records for CVA's, 44 patients had
screening adherence. From the 85 remaining records, 29 did not have screening adherence and
56 records did not meet the criteria. Patient demographic variables were obtained and included
age, race, and gender. Other patient characteristics, that were not part of the study objectives,
were evaluated to see if patients had incidents such as: BMI, pacemaker present, admission
diagnosis of MI (DRG 280-282) or CVA (061-068), intubation, tachycardia, bradycardia, and the
presence of Atrial fibrillation or Aflutter. The primary investigator was evaluating any
association between these incidents and OSA.
Data Analysis
Part one of the study evaluated effectiveness of the implementation of the protocol by
determining the percentage of the registered nurses who received training on how to use the
STOP BANG protocol. There was a desired goal of at least 75% of the nurses from the ICU and
5 East Cardiac unit to attend training. Descriptive statistics were utilized to measure the
percentage of nurses that attended training and participated in the study. Part two used
descriptive statistics for objective two, as a percentage to measure the protocol screening
adherence, or the percentage of patient charts that were screened. No data analysis was used to
for objective 3 to display why there was screening non-adherence, there were no notes made in
the charts by the nurses on why there was non-adherence. For objectives 4 and 5 the Chi-Square
test was used to examine any association/correlation between the use of supplemental oxygen
and the use of BiPAP and positive STOP BANG screens. For objective 6, descriptive statistics
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was used as a percentage of the number of charts that had notes placed in them stating an
education handout was given to positive screened patients. Other confounding variables that
were not part of the 6 objectives, such as patient demographics and patient characteristics, were
examined and analyzed that could potentially affect the degree of association with positive STOP
BANG screens. Patient demographics included age, race and gender. Patient characteristics
included BMI, pacemaker present, admission diagnosis of MI (DRG 280-282) or CVA (061068), intubation, tachycardia, bradycardia, and the presence of Atrial fibrillation or Aflutter.
Within these demographics and characteristics, the Paired t-test was used to compare continuous
variables, and the Chi-Square Test was used to analyze categorical variables. In cases were the
Chi-Square or Paired t-test could not be used, the Fisher's Exact Test or Levene's Equality for
Variances was used. For statistical analysis, the Statistical Package for the Social Sciences
(SPSS) version 23; was utilized, and a level of P<.05 was used for statistical significance
throughout.
Results
For objective 1, among the ICU nurses, after being approached by the primary
investigator, 63 out of 80 nurses or 78% participated voluntarily in the study. These
participating nurses signed an informed consent provided by the primary investigator explaining
the study. The participating nurses were then educated on how to use and implement the STOP
BANG protocol. Among the 5 East Cardiac unit nurses, all 5 nurses or 100% participated
voluntarily, signed inform consent and were educated on how to use and implement the STOP
BANG protocol. Nurses that decided not participate in the study simply stated they did not feel
comfortable participating or they did not want to add voluntary work to their required duties.
For objective 2, a total of 119 combined CVA and MI records met the inclusion criteria for
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screening. From the 119 records 73 of these were CVA's and 46 were MI's. A total of 62
records had screening adherence. Among the 73 stroke patient records that met the inclusion
criteria, 44 had screening adherence, and 29 had non-adherence, which yielded a 60% adherence
rate for the ICU. From the ICU 3E unit, screening was non-adherent on 14 of the CVA records,
and on 5W screening was non-adherent on 15 of the CVA records. The 5 East Cardiac unit does
not admit CVA patients. Among the 46 MI patient records that met the inclusion criteria, 18 had
screening adherence which yielded a 39% adherence rate for the ICU and 5 East Cardiac units
combined. From the 5 East unit, screening was non-adherent on 20 MI records, ICU 5W was
non-adherent on 4 MI records and 3E was non-adherent on 4 MI records. For the 29 CVA
records and 28 MI records that were non-adherent in screening, no note was made in the patient's
chart as to why the screening was not completed. Among the 62 screened patients, for all units
the number of days to be screened revealed an average of 1.93 days (SD=1.367, range= 0-6).
Among the 62 records with screening adherence, 18 records or 29% screened positive
with a STOP BANG score between 5-8, which consisted of 11 CVA's or 18%, 6 NSTEMI's or
9% and 1 STEMI or 2%. For objective 4, analysis of chart data revealed that the proportion
among the 18 patients who screened positive, 8 or 44% required supplemental oxygen. Using
the Chi-Square/Fisher's Exact Test, the result revealed a P value of .214, which showed no
association or correlation between the use of supplemental oxygen and a positive STOP BANG
screen. For objective 5, in examining those who screened negative vs positive and required the
use of BiPAP during nighttime hours the following results were revealed: For positive screens,
2 patients or 11 % required the use of BiPAP during nighttime hours, using the Fisher's Exact
Test, this revealed a P value of .074, which showed no association or correlation statistically
between positive screens with the use of BiPAP and positive STOP BANG screens, but did show
14

clinical significance. For negative screens, 16 patients or 89% did not required BiPAP use
during nighttime hours. Using the Fisher's Exact Test, this revealed a P value of 1.000, which
showed no association or correlation statistically between negative screens with the use of
BiPAP. These results revealed no association or correlation between positive vs negative
screens and the use of BiPAP during nighttime hours. For objective 6, in examining the
frequency of notes made in the charts for positive screens, out of 18 positive screens, 9 notes or
50% were placed in the charts. Out of those 9 notes, 6 notes were placed in the records of
patients with CVA's, and 3 for MI's. These results pertained to the 6 objectives research
questions.
The confounding variables that were not implicitly in the objectives, such as patient
demographics and patient characteristics were of interest and used to describe the secondarypopulation within the ICU and 5 East Cardiac units. These variables could have a potential
effect on the degree of association between positive screened patients and objectives 4 and 5.
The results for the patient demographics were as follows: For positive screens the mean age of
all patients was 63.22 years (SD=9.662). Using the Levene's Test of Equality for Variances this
resulted in a P value of .928, which showed no association or correlation between age and a
positive STOP BANG screen. For positive screens and race, using the Fisher's Exact Test this
resulted in a P value of .550, which showed no association or correlation between race and
positive STOP BANG screens. For positive screens among gender, there were 13 males and 5
females, using the Chi-Square Test for comparison, the P value result was .025, which showed a
higher association or correlation between a positive STOP BANG screen among male vs female.
Among the confounding patient characteristic variables, the results were as follows: The BMI of
positive screened patients demonstrated a mean value of 32.06 (SD = 6.812), using the Levene's
15

Test for Equality of Variances, a P value result of .005 was revealed. This demonstrated an
association or correlation between a higher BMI and a positive STOP BANG screen. Among
arrhythmias, no association or correlations were found between arrhythmias or the presence of
OSA. Using the Chi-Square Test, the results were as follows: Tachycardia revealed a P value of
.538, Bradycardia revealed a P value of .444, A-Fib revealed a P value of 1.000, and no A-Flutter
was present among positive screens. Among those patients with positive screens who had
pacemakers the results revealed a P value of 1.000, which showed no association or correlation
between pacemakers and the presence a positive STOP BANG screen. Finally, for positive
screens that were intubated, the result revealed a P value of 1.000, which showed no association
or correlation between intubation and a positive STOP BANG screen. It is important to note that
no proportion of the sample reported a pre-existing diagnosis of OSA, including the 18 positive
screens.
Discussion

Within the 6 objectives, the major findings of this study showed that the primary
population of nurse providers had a 78% participation rate from the ICU and 100% participation
rate from the 5 East Cardiac unit. This finding is important because without participation there is
no study. No similar studies could be found specifically to OSA screening within the acute care
setting, however a 2012 psychology research paper found that drops in participation caused
drops in the confidence of research findings. A 100% participation rate is perfect but not always
possible. The paper mentioned that in reviewing standard research texts, a number was not
identified for a participation rate to exceed to be scientifically acceptable, although some
researchers mentioned 60%, 80% or 90% as the target participation rate (Journal of
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Psychotherapy and Psychosomatics, 2012). The clinical relevance of this is important because a
drop in the confidence of research could potentially effect evidence based practice within the
clinical setting. The findings for the STOP BANG screening adherence rate was 60% for the
CVA population and 39% for the MI population. It is difficult to determine the reasons for 62%
low adherence rates for MI's due to notes not being placed within charts that were not screened.
Another factor that may have affected screening from the 5 East unit was work burden. The
participating nurses from this unit were also assistant nurse managers that not only had patient
teams, but were also required to fulfill administrative duties. Findings from this study suggest
that there are no associations or correlations between positive screens and the use of
supplemental oxygen or BiPAP use. Although, clinical significance was found between positive
screens and the use of BiPAP which simply means there is practical importance, and is a
subjective interpretation of the result by a provider.
The major findings of the confounding demographic variables not implicitly stated in the
objectives showed there is no association or correlation between positive screens and age or race.
However, there was an association or correlation between positive screens with males and
positive screens. Among the confounding patient characteristic variables, there was an
association or correlation between positive screens and BMI and positive screens. This finding
was important since these are known characteristics of patients already diagnosed with OSA
(Chui et al. 2017). No associations or correlations were found between the remaining
confounding patient characteristic variables such as tachycardia, bradycardia, A-Fib, A-Flutter,
the presence of a pacemaker, and intubated patients with a positive STOP BANG screen.
There is currently no required screening protocol at NBH with the STOP-BANG or any
other tool for OSA. Education and "buy-in" of nurses on evidence-based OSA screening process
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are important factors in helping to identify OSA in patients with MI or CVA. The medical
consequences of not identifying undiagnosed OSA in these populations would not allow to the
providers or patients options for treatment to potentially improve outcomes.
Limitations
This study had limitations with small sample sizes, as well as only being implemented on
2 units within 1 facility. Poor adherence to the STOP BANG screening protocol and a short
implementation period were other study limitations. Poor adherence rates limits data collection
and the validity of the study. A longer duration period may have allowed larger sample sizes
which could have yielded different results. The convenience sample of the patient population
was mostly white in those who were screened and there were no minorities in the positive
screens. Another limitation was self-reporting as this is not completely reliable, patients may
sometimes not be aware that they snore or have other symptoms. There were however times
when family would report for a patient.
Recommendations for Future Study
Steps must be taken to further asses the burden of OSA on the MI and CVA populations
as well as increase provider awareness and screening. Within this study, there was limited
evidence to reveal the burden of OSA on these populations. It is important to study the burden
on these populations as literature has shown OSA is an independent risk factor for cardiovascular
disease. A large scale multi-unit, multi-level, multi-facility comparison with a longer duration
period must be conducted to gain larger sample sizes to better understand the burden on these
populations for more reliable and generalizable results. This could be accomplished by getting
buy-in from stakeholders throughout the Norton system on the need for OSA screening by
presenting evidence-based research showing the implications and costs of untreated OSA, and
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how it could impact readmission rates. This would improve provider awareness and aide in the
implementation process of OSA screening through better stakeholder support. In addition to
expanding studies to other facilities, increasing the evaluation period would also be beneficial in
identifying trends over time. A long evaluation period would give the results stronger reliability
and validity. To improve non-adherence rates, post implementation surveys to the providers
should be conducted to evaluate reasons for non-adherence. Future research questions may ask
why non-adherence is prevalent within the OSA screening process. Other research questions
may ask, what providers should conduct OSA screening within the acute care setting, how
prevalent is OSA among races other than whites, and what is the burden of OSA on the heart
failure population. Other patient characteristics should be tracked such admission diagnosis, the
use of oxygen or CPAP, and desaturation events during the night and socio-economic status. It
would also be important to measure the co-morbid burden in the sample between positive and
negative screens for OSA risk and mortality. Further development of a treatment protocol for
those who screened positive for being at increased risk for OSA is needed to ensure follow up.
Conclusion
There are currently no recommendations on screening for OSA in the acute care setting.
According to an article by the U.S. Preventive Task Force (2017), screening is not recommend
for OSA in asymptomatic adults. Within the same article, the American College of Physicians
does recommend a sleep study for those with daytime sleepiness, and The American Academy of
Sleep Medicine recommends that routine health maintenance evaluations include questions about
OSA and evaluation for risk factors (U.S. Preventive Task Force, 2017). In an article by Kapur
et al. (2017), The American Academy of Sleep Medicine (AASM) reports that an estimated 30
million people in the U.S. suffer from sleep apnea. The AASM does not mention screening
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questionnaires for sleep apnea but does recommend an attended polysomnography in an
accredited sleep center or home sleep apnea testing should be performed for suspected
obstructive sleep apnea, (Kapur et al., 2017).
One of the aims of this study was to show the burden of OSA on the MI and CVA
populations in the acute care settings, and evaluate the use of supplemental oxygen or the use of
BiPAP and associations with positive STOP BANG screens, these were objectives 4 and 5. No
significance correlation was found between the use of supplemental oxygen or the use of BiPAP
and positive screens. Within the special interest variables, a significant correlation was found
between males and positive screens vs females. A significant correlation was also found
between a higher BMI and positive screens. Although no significant correlations were found
within objectives 4 and 5, this does not mean that screening should not be performed on these
populations as results could be more reliable and generalizable with larger sample sizes.
One problem is the lack of knowledge from providers on the negative health effects of
OSA due to a lack of standardized screening guidelines. It is unknown within this study how
well the STOP BANG screening instrument identified OSA symptoms in patients with a known
diagnosis of OSA. From the positive screened patients, none were known to have a prior
diagnosis of OSA. Screening is important as studies have shown that proper treatment of OSA
can have positive health effects. In this study, no correlation was found between Atrial
Fibrillation and the presence of OSA, but a recent article concluded that studies of patients with
Atrial Fibrillation suggest that there is a significant correlation between treatment of OSA by
continuous positive airway pressure and maintaining sinus rhythm after electrical cardioversion,
and improve catheter ablation success rates (Lintz et al., 2018).
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A study by Olga et al. (2014),

found results which found a significant correlation between CPAP therapy and a positive effect
on the long‐term survival in patients with ischemic stroke.
Without standardized guidelines for the screening of OSA within the acute care setting, a
lack of awareness will continue to exist. More research must be conduct and steps must be taken
to bring knowledge and awareness of OSA and its burden on cardiovascular disease populations
so that screening processes may be implemented. In the next steps, it would be reasonable to
educate all major stakeholders within the Norton Brownsboro Hospital on the impact of
untreated OSA on cardiovascular health and associated costs. By utilizing this information and
using a framework model such as the Iowa Evidence-based Practice Model, it would be feasible
to continue an evidence-based practice such as the STOP BANG screening instrument and
continue risk screening for OSA at Norton Brownsboro and eventually throughout the Norton
system. This pilot study was successful with high nurse participation and adherence rates and
could be improved by including future treatment plans developed for positive screened patients
requiring supplemental oxygen to CPAP while hospitalized, and follow up appointments post
discharge. There are major opportunities for prevention focus with a treatment plan for those
who screen positive. The next steps for future screening would include follow-ups on those
patients who scored between 5-8. On patients who screen positive, information such as time
intervals, when was oxygen added, did they require CPAP or go home with a CPAP, and did
they have a follow up sleep study, would allow a fuller understanding of the patient's clinical
course. This must be accomplished before we can understand and look for linkages between
screening positive on the STOP BANG OSA risk assessment and readmission rates. This
work/study could potentially have influence on reducing readmission rates and costs.
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Table 1. Inclusion List of Myocardial Infarction DRG codes n=52
Inclusion Criteria List of Myocardial DRG codes
DRG Codes

Diagnosis Definition

280

ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W MCC

281

ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W CC

282

ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W/O CC/MCC

Table 2. Inclusion List of Stroke DRG codes n=129
DRG Codes

Diagnosis Definition

061

Ischemic stroke, precerebral occlusion or transient ischemia with thrombolytic agent
with mcc

062

Ischemic stroke, precerebral occlusion or transient ischemia with thrombolytic agent
with cc

063

Ischemic stroke, precerebral occlusion or transient ischemia with thrombolytic agent
without cc/mcc

064

Intracranial hemorrhage or cerebral infarction with mcc

065

Intracranial hemorrhage or cerebral infarction with cc or tpa in 24 hours

066

Intracranial hemorrhage or cerebral infarction without cc/mcc

067

Nonspecific cva and precerebral occlusion without infarction with mcc

068

Nonspecific cva and precerebral occlusion without infarction without mcc

22

Table 3. Demographic Characteristics
Characteristic
Age
BMI
Gender
Male
Female
Race
Blk
Cauc
Admitting Dx
CVA
NSTEMI
STEMI
Screening Outcomes
Pacemaker
Positive screens
Negative screens
Tachycardia
Positive screens
Negative screens
Bradycardia
Positive screens
Negative screens
A fib
Positive screens
Negative screens
Vent
Positive screens
Negative screens
Aflutter
Negative screens
Desaturation during stay
Positive screens
Negative screens
Negative screen with BiPAP
Positive
Negative
Positive screen with BiPAP
Positive
Negative

Mean (SD) or n (%)
63.44 (14.400)
28.87 (6.244)
31 (50%)
31 (50%)
3 (4.8%)
59 (95.2)
44 (71%)
13 (21%)
5 (8.1%)
Mean (SD or n (%)
4 (6.5%)
57 (91.9%)
18 (29%)
43 (69.4%)
23 (37.1%)
39 (62.9%)
2 (3.2%)
59 (95.2%)
6 (9.7%)
55 (88.7%
62 (100%)
8 (12.9%)
54 (87.1%)
2 (3.2%)
60 (96.8%)
2 (3.2%)
60 (96.8%)
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Table 4. Comparison of characteristics

Age
BMI
Gender
Male
Female
Race
Caucasian
Black
Admitting Dx
CVA
NSTEMI
STEMI
Pacemaker

Screened positive (n=)

Screened negative (n=)

Mean (SD) or n (%)
63.22 (9.62)
32.06 (6.812)

Mean (SD)
63.52 (16.038)
27.28 (5.473)

13 (72.2%)
5 (27.8%

18 (40.9%)
26 (59.1%)

18 (100%)
0

41 (93.2%)
3 (6.8%)

P

.93
.005
.025
.550

.302
11 (61.1%)
6 (33.3%)
1 (5.6%)
1 (5.9%) OSA
17 (94.1%)

33 (75%)
7 (15.9%)
4 (9.1%)
CVA 41 (93.2%)
MI 3 (6.8%)

Tachycardia

6 (35.3%) OSA
11 ((%64.7)

12 (27.3%)
32 (72.7%)

.538

Bradycardia

8 (44.4%) OSA
10 (55.6)

15 (34.1%)
29 (5.9%)

.444

Intubated

4 (9.1%)
40 (90.9%)
0%

1.000

Aflutter

2 (11.8%) OSA
16 (88.2%)
0%

Desaturation during
stay

4 (22.2%) OSA
14 (77.8%)

4 (9.1%)
40 (90.9%)

.214

Negative BiPAP screen

0 OSA
18 (100%)

2 (4.5%)
42 (95.5%)

1.000

Positive BiPAP screen

3 (11.8%) OSA
15 (88.2%)

0 (0%)
44 (100%)

.074
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(Appendix B) Patient Education Handout

STOP BANG Patient Education
Handout
Because of being in the ICU, a special test was done on you called the STOP
BANG test to check for obstructive sleep apnea. Your result indicates that you
may be at risk for sleep apnea. This tool is only used to assess your risk of having
obstructive sleep apnea and not a diagnosis. Having obstructive sleep apnea puts a
person at higher risk for heart attack and stroke. You are encouraged to follow up
with your primary care physician after discharge and potentially setting up a sleep
study workup.
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(Appendix C) Audit Tool for patient data Post-Implementation
Unique Age Race BMI Admit Pacer On
Tachy‐ Brady AFIB
Screen
ID
dx
Y/N
vent cardia cardia Aflutter completed
1A
1B
1C

Unique
ID

Reason
not

Positive
screen

Adhered
to

O2 Range

Desaturation
During ICU
stay

Negative
screen

Positive
screen

With BiPAP With
BiPAP

1A
1B
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Education
Handout
Given

Note
Made in
Chart

